Stock Track | Oruka Therapeutics Soars 5.25% Intraday on Multiple Analyst Upgrades

Stock Track

03/13

Shares of Oruka Therapeutics Inc (ORKA) surged 5.25% during intraday trading on Friday, driven by a wave of positive analyst actions.

The stock's rise follows several bullish reports from financial institutions. Guggenheim reiterated a Buy rating with a $60 price target, Barclays raised its target price to $50 from $48, and Stifel significantly increased its target to $72 from $47. These upgrades reflect growing analyst optimism regarding the company's prospects in the healthcare sector.

Such coordinated positive sentiment from multiple analysts often fuels investor confidence, leading to increased buying activity and upward price movement in the stock.

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/news/1190686525"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1190686525\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1190686525?lang=zh_CN&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-03-13 21:32","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1190686525","market":"hk","top_or_hot":-1,"title":"Stock Track | Oruka Therapeutics Soars 5.25% Intraday on Multiple Analyst Upgrades","media":"Stock Track","content":"<p>Shares of Oruka Therapeutics Inc (ORKA) surged 5.25% during intraday trading on Friday, driven by a wave of positive analyst actions.</p><p>The stock's rise follows several bullish reports from financial institutions. Guggenheim reiterated a Buy rating with a $60 price target, Barclays raised its target price to $50 from $48, and Stifel significantly increased its target to $72 from $47. These upgrades reflect growing analyst optimism regarding the company's prospects in the healthcare sector.</p><p>Such coordinated positive sentiment from multiple analysts often fuels investor confidence, leading to increased buying activity and upward price movement in the stock.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | Oruka Therapeutics Soars 5.25% Intraday on Multiple Analyst Upgrades</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | Oruka Therapeutics Soars 5.25% Intraday on Multiple Analyst Upgrades\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time\">2026-03-13 21:32</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Shares of Oruka Therapeutics Inc (ORKA) surged 5.25% during intraday trading on Friday, driven by a wave of positive analyst actions.</p><p>The stock's rise follows several bullish reports from financial institutions. Guggenheim reiterated a Buy rating with a $60 price target, Barclays raised its target price to $50 from $48, and Stifel significantly increased its target to $72 from $47. These upgrades reflect growing analyst optimism regarding the company's prospects in the healthcare sector.</p><p>Such coordinated positive sentiment from multiple analysts often fuels investor confidence, leading to increased buying activity and upward price movement in the stock.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"ORKA","symbol_name":"ORUKA THERAPEUTICS INC","start_time":0,"source_url":"","article_id":"1190686525","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1190686525","pubTimestamp":1773408757,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"Shares of Oruka Therapeutics Inc (ORKA) surged 5.25% during intraday trading on Friday, driven by a wave of positive analyst actions.The stock's rise follows several bullish reports from financial...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"ORKA":"ORUKA THERAPEUTICS INC"},"translate_title":"个股追踪|多位分析师上调评级Oruka Therapeutics盘中大涨5.25%","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"ORKA":1},"content_text":"Shares of Oruka Therapeutics Inc (ORKA) surged 5.25% during intraday trading on Friday, driven by a wave of positive analyst actions.The stock's rise follows several bullish reports from financial institutions. Guggenheim reiterated a Buy rating with a $60 price target, Barclays raised its target price to $50 from $48, and Stifel significantly increased its target to $72 from $47. These upgrades reflect growing analyst optimism regarding the company's prospects in the healthcare sector.Such coordinated positive sentiment from multiple analysts often fuels investor confidence, leading to increased buying activity and upward price movement in the stock.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"movement","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"}}}